[go: up one dir, main page]

PE20130387A1 - Composicion farmaceutica y combinacion y metodos para tratar las enfermedades o las condiciones asociadas con la enfermedad o condicion respiratoria - Google Patents

Composicion farmaceutica y combinacion y metodos para tratar las enfermedades o las condiciones asociadas con la enfermedad o condicion respiratoria

Info

Publication number
PE20130387A1
PE20130387A1 PE2013000107A PE2013000107A PE20130387A1 PE 20130387 A1 PE20130387 A1 PE 20130387A1 PE 2013000107 A PE2013000107 A PE 2013000107A PE 2013000107 A PE2013000107 A PE 2013000107A PE 20130387 A1 PE20130387 A1 PE 20130387A1
Authority
PE
Peru
Prior art keywords
pharmaceutical composition
polyclonal
monoclonal
condition
methods
Prior art date
Application number
PE2013000107A
Other languages
English (en)
Inventor
Oleg Iliich Epshtein
Original Assignee
Oleg Iliich Epshtein
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44899162&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20130387(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from RU2010130352/15A external-priority patent/RU2528093C2/ru
Priority claimed from RU2011125992/15A external-priority patent/RU2529783C2/ru
Application filed by Oleg Iliich Epshtein filed Critical Oleg Iliich Epshtein
Publication of PE20130387A1 publication Critical patent/PE20130387A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39583—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials not provided for elsewhere, e.g. haptens, coenzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A61K2039/507—Comprising a combination of two or more separate antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Endocrinology (AREA)
  • Pulmonology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Otolaryngology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

SE REFIERE A UNA COMPOSICION FARMACEUTICA QUE COMPRENDE: A) UN ANTICUERPO MONOCLONAL, POLICLONAL O NATURAL POTENCIADO Y ACTIVADO CONTRA LA BRADIQUININA QUE TIENE LA SECUENCIA DE AMINOACIDOS SEQ ID Nº 1; B) UN ANTICUERPO MONOCLONAL, POLICLONAL O NATURAL POTENCIADO Y ACTIVADO CONTRA LA HISTAMINA; Y C) UN ANTICUERPO MONOCLONAL, POLICLONAL O NATURAL POTENCIADO Y ACTIVADO CONTRA LA MORFINA; EN DONDE LA COMPOSICION ES PREPARADA A TRAVES DE UNA SOLUCION CONSECUTIVA REPETITIVA Y LA AGITACION VARIAS VECES DE CADA SOLUCION OBTENIDA DE ACUERDO A LA TECNOLOGIA HOMEOPATICA Y LA POSTERIOR COMBINACION IMPREGNANDO ALTERNATIVAMENTE UN EXCIPIENTE CON DICHA SOLUCION COMBINADA O CON SOLUCIONES POR SEPARADO. DICHA COMPOSICION ES UTIL EN EL TRATAMIENTO DE LAS INFECCIONES DE LAS VIAS RESPIRATORIAS, TOS
PE2013000107A 2010-07-21 2011-07-15 Composicion farmaceutica y combinacion y metodos para tratar las enfermedades o las condiciones asociadas con la enfermedad o condicion respiratoria PE20130387A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU2010130352/15A RU2528093C2 (ru) 2010-07-21 2010-07-21 Фармацевтическая композиция и способ лечения острых и хронических заболевания дыхательной системы и синдрома кашля
RU2011125992/15A RU2529783C2 (ru) 2011-06-24 2011-06-24 Лекарственное средство для лечения патологического синдрома и способ лечения острых и хронических заболеваний дыхательноый системы и синдрома кашля

Publications (1)

Publication Number Publication Date
PE20130387A1 true PE20130387A1 (es) 2013-03-30

Family

ID=44899162

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2013000107A PE20130387A1 (es) 2010-07-21 2011-07-15 Composicion farmaceutica y combinacion y metodos para tratar las enfermedades o las condiciones asociadas con la enfermedad o condicion respiratoria

Country Status (22)

Country Link
US (2) US8795657B2 (es)
EP (1) EP2595655A2 (es)
JP (2) JP2013533269A (es)
CN (1) CN103200964A (es)
AR (1) AR082313A1 (es)
AU (1) AU2011281247B2 (es)
BR (1) BR112013001297A2 (es)
CA (1) CA2805978C (es)
CL (1) CL2013000202A1 (es)
DE (1) DE112011102412T5 (es)
EA (1) EA029228B1 (es)
ES (1) ES2425315R1 (es)
FR (1) FR2962909A1 (es)
GB (1) GB2496800B (es)
IT (1) ITTO20110638A1 (es)
MX (1) MX356678B (es)
MY (1) MY158522A (es)
NZ (1) NZ606977A (es)
PE (1) PE20130387A1 (es)
PH (1) PH12013500142A1 (es)
SG (1) SG187579A1 (es)
WO (1) WO2012010973A2 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2181297C2 (ru) * 2000-06-20 2002-04-20 Эпштейн Олег Ильич Способ лечения патологического синдрома и лекарственное средство
RU2309732C1 (ru) * 2006-03-13 2007-11-10 Олег Ильич Эпштейн Спрессованная твердая оральная форма лекарственного препарата и способ получения твердой оральной формы лекарственного препарата
GB2495884B (en) 2010-07-15 2017-05-31 Iliich Epshtein Oleg A method of increasing the effect of an activated-potentiated form of an antibody
JP2013532182A (ja) 2010-07-15 2013-08-15 イリイチ・エプシテイン オレグ 組み合わせ医薬組成物及び神経変性疾患に関連する疾患又は状態を治療する方法
PH12013500141A1 (en) * 2010-07-21 2013-03-11 Oleg Lliich Epshtein Combination pharmaceutical compositions and method of treatment of vertigo, kinetosis and vegetative-vascular dystonia
ES2445846R1 (es) * 2010-07-21 2015-01-02 Oleg Iliich Epshtein Una composición de combinación farmacéutica y su uso para preparar un medicamento destinado al tatamiento de la diabetes de tipo l y los trastornos metabólicos
PH12013500142A1 (en) * 2010-07-21 2013-03-11 Oleg Iliich Epshtein Combination pharmaceutical composition and methods of treating diseases or conditions associated with respiratory disease or condition
GB2496343B (en) 2010-07-21 2017-11-01 Iliich Epshtein Oleg A method of treating attention deficit hyperactivity disorder
JP2013537532A (ja) * 2010-08-06 2013-10-03 イリイチ・エプシテイン オレグ 感染性疾患を治療及び予防する組み合わせ医薬組成物及び方法
RU2013111962A (ru) 2013-03-18 2014-09-27 Олег Ильич Эпштейн Способ определения выраженности модифицирующей активности, ассоциированной с носителем
RU2013111961A (ru) 2013-03-18 2014-09-27 Олег Ильич Эпштейн Способ определения выраженности модифицирующей активности, ассоциированной с носителем
DE102020007979A1 (de) 2020-12-29 2022-06-30 Charité Universitätsmedizin Institut für Mikrobiologie und Infektionsimmunologie Zusammensetzung zur Behandlung von lnfektionen mit Coronaviren

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4311897A (en) 1979-08-28 1982-01-19 Union Carbide Corporation Plasma arc torch and nozzle assembly
CA2146647C (en) 1992-10-08 2009-05-05 Marc Feldmann Treatment of autoimmune and inflammatory disorders
IT1261849B (it) 1993-09-02 1996-06-03 Avantgarde Spa Dispositivo medico per la somministrazione di principi attivi o farmaci a bassissimo dosaggio, in particolare di farmaci omeopatici.
US5629286A (en) 1994-03-31 1997-05-13 Brewitt; Barbara Homeopathic dilutions of growth factors
IL110035A0 (en) 1994-06-16 1994-10-07 Tapuach Natural Technologies 1 Homeopathic formulations
CA2251617A1 (en) 1996-02-12 1997-08-14 Oleg Iliich Epshtein Medicament and method of treating an organism with medicaments
US5834443A (en) * 1996-05-21 1998-11-10 Masiello; Domenick J. Composition and method for treating herpes simplex
RU2114646C1 (ru) 1996-09-30 1998-07-10 Олег Ильич Эпштейн Способ повышения защитных свойств организма при воздействии внешних физических факторов
RU2103999C1 (ru) 1997-01-31 1998-02-10 Олег Ильич Эпштейн Способ лечения алкоголизма
RU2181297C2 (ru) 2000-06-20 2002-04-20 Эпштейн Олег Ильич Способ лечения патологического синдрома и лекарственное средство
RU2199244C2 (ru) * 2000-10-05 2003-02-27 Самофалова Лариса Александровна Способ получения пищевой муки масличных семян
RU2191602C1 (ru) 2001-06-01 2002-10-27 Эпштейн Олег Ильич Лекарственное средство и способ лечения аллергических и псевдоаллергических реакций
RU2197266C1 (ru) * 2001-06-01 2003-01-27 Эпштейн Олег Ильич Лекарственное средство и способ лечения эрозивных и воспалительных заболеваний желудочно-кишечного тракта
RU2206338C1 (ru) 2001-12-07 2003-06-20 Эпштейн Олег Ильич Способ лечения синдрома кашля
RU2199344C1 (ru) * 2001-12-07 2003-02-27 Эпштейн Олег Ильич Лекарственное средство и способ лечения синдрома кашля
RU2199345C1 (ru) 2001-12-26 2003-02-27 Эпштейн Олег Ильич Лекарственное средство и способ регуляции углеводного и жирового обмена
RU2209083C1 (ru) 2001-12-26 2003-07-27 Эпштейн Олег Ильич Лекарственное средство и способ лечения кашля
RU2201255C1 (ru) 2001-12-26 2003-03-27 Эпштейн Олег Ильич Лекарственное средство и способ регуляции сосудистого тонуса
UA76639C2 (uk) 2002-08-02 2006-08-15 Олєг Ільіч Епштєйн Гомеопатичний лікарський засіб та спосіб лікування еректильних дисфункцій
UA76638C2 (en) 2002-08-02 2006-08-15 Oleh Illich Epshtein Homeopathic medication based on anti-interferon antibodies and method for treating a pathological syndrome associated with interferon
UA76641C2 (uk) 2002-08-02 2006-08-15 Олєг Ільіч Епштєйн Гомеопатичний лікарський засіб та спосіб лікування захворювань передміхурової залози
CA2518965C (en) 2003-03-14 2018-10-30 Nutrition Research Inc. Homeopathic formulations useful for treating pain and/or inflammmation
RU2253478C1 (ru) 2003-10-01 2005-06-10 Эпштейн Олег Ильич Средство для потенцирования лечебных эффектов - усиления действия лекарственного вещества
US9308259B2 (en) * 2006-06-06 2016-04-12 Oleg Iliich Epshtein Medicinal agent for treating fatness, diabetes, and diseases associated with impaired glucose tolerance
SG190594A1 (en) * 2008-04-29 2013-06-28 Gunvant Devichand Oswal A homeopathic formulation
PH12013500108A1 (en) 2010-07-15 2017-01-06 Oleg Iliich Epshtein Combination pharmaceutical composition and methods of treating functional diseases or conditions of gastrointestinal tract
AU2011278042B2 (en) 2010-07-15 2017-02-16 Oleg Iliich Epshtein Combination pharmaceutical composition and methods of treating genitourinary system disorders
EE05760B1 (et) * 2010-07-15 2016-03-15 Olegiliich Epshtein Ravimkoostis
JP2013532182A (ja) 2010-07-15 2013-08-15 イリイチ・エプシテイン オレグ 組み合わせ医薬組成物及び神経変性疾患に関連する疾患又は状態を治療する方法
ES2445846R1 (es) 2010-07-21 2015-01-02 Oleg Iliich Epshtein Una composición de combinación farmacéutica y su uso para preparar un medicamento destinado al tatamiento de la diabetes de tipo l y los trastornos metabólicos
PH12013500142A1 (en) * 2010-07-21 2013-03-11 Oleg Iliich Epshtein Combination pharmaceutical composition and methods of treating diseases or conditions associated with respiratory disease or condition
PH12013500141A1 (en) * 2010-07-21 2013-03-11 Oleg Lliich Epshtein Combination pharmaceutical compositions and method of treatment of vertigo, kinetosis and vegetative-vascular dystonia
JP2013537532A (ja) 2010-08-06 2013-10-03 イリイチ・エプシテイン オレグ 感染性疾患を治療及び予防する組み合わせ医薬組成物及び方法

Also Published As

Publication number Publication date
AU2011281247A1 (en) 2013-03-14
GB2496800A (en) 2013-05-22
GB2496800B (en) 2018-05-23
CA2805978C (en) 2016-06-28
GB201302926D0 (en) 2013-04-03
CN103200964A (zh) 2013-07-10
WO2012010973A2 (en) 2012-01-26
FR2962909A1 (fr) 2012-01-27
AU2011281247B2 (en) 2015-07-30
WO2012010973A3 (en) 2012-04-26
US20150023985A1 (en) 2015-01-22
CA2805978A1 (en) 2012-01-26
SG187579A1 (en) 2013-03-28
ES2425315A2 (es) 2013-10-14
EA029228B1 (ru) 2018-02-28
EA201300131A1 (ru) 2013-11-29
JP2013533269A (ja) 2013-08-22
CL2013000202A1 (es) 2015-01-16
ES2425315R1 (es) 2014-09-08
ITTO20110638A1 (it) 2012-01-22
BR112013001297A2 (pt) 2017-11-21
NZ606977A (en) 2015-08-28
US20120225074A1 (en) 2012-09-06
DE112011102412T5 (de) 2013-07-04
PH12013500142A1 (en) 2013-03-11
US8795657B2 (en) 2014-08-05
EP2595655A2 (en) 2013-05-29
MY158522A (en) 2016-10-14
AR082313A1 (es) 2012-11-28
JP2016216479A (ja) 2016-12-22
MX2013000806A (es) 2013-10-28
MX356678B (es) 2018-06-08

Similar Documents

Publication Publication Date Title
PE20130387A1 (es) Composicion farmaceutica y combinacion y metodos para tratar las enfermedades o las condiciones asociadas con la enfermedad o condicion respiratoria
AR082149A1 (es) Anticuerpos contra el virus sincicial respiratorio (rsv) humano y metodos para su uso
CO6341486A2 (es) Tratamiento y profilaxis de amiloidosis
AR083740A1 (es) Anticuerpos dkk1 (dickkopf-1) y metodos de uso
NZ606765A (en) Combination pharmaceutical composition and methods of treating functional diseases or conditions of gastrointestinal tract
UA109658C2 (xx) Антитіло проти cgrp
MX2010004482A (es) Anticuerpos anti-proteina g vsr.
BR112012018951C8 (pt) anticorpo monoclonal, composição farmacêutica, combinação farmacêutica, uso de um anticorpo, uso de uma composição farmacêutica e uso de uma combinação farmacêutica
PE20180499A1 (es) Anticuerpos de union a tau
EA201490004A1 (ru) Применение bifidobacterium lactis bl-04 для лечения заболеваний дыхательных путей
EA201171285A1 (ru) Новая технология изготовления диклофенака
UA110806C2 (uk) Мікобактеріальна антигенна композиція
BR112012019098A2 (pt) composição farmacêutica, combinação farmacêutica e método para o tratamento e/ou prevenção de um câncer e anticorpo
RU2011142183A (ru) Средство для лечения ревматоидного артрита
MX2015009963A (es) Metodos y composición farmacéutica para el tratamiento y la prevención de cardiomiopatía debido a falta de energía.
EA201171286A1 (ru) Новая технология изготовления индометацина
EA201171284A1 (ru) Новая технология изготовления напроксена
FI20135146A7 (fi) Farmaseuttiset koostumukset ja hoitomenetelmät
UA113623C2 (uk) Моноклональне антитіло проти інгібітору шляху тканинного фактора (tfpi)
EA201300988A1 (ru) Мягкая фармацевтическая композиция на водной основе, содержащая тапентадол
EA201691020A1 (ru) Способы лечения и предотвращения вызываемой аллогенными антителами хронической болезни "трансплантат против хозяина"
ES2555557R1 (es) Fármaco y uso para preparar un medicamento destinado a la prevención de la infección del VIH y al tratamiento de enfermedades causadas por el VIH, incluido el SIDA
EA201892409A1 (ru) Способы лечения заболеваний, при которых активность il-13 оказывает негативное влияние, с применением антител против il-13
MX2018008078A (es) Tecnologia de sinergismo anticuerpo-farmaco para el tratamiento de enfermedades.
UA107836C2 (uk) Метод лікування хвороби альцгеймера

Legal Events

Date Code Title Description
FC Refusal